Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center

J Clin Immunol. 2009 May;29(3):357-64. doi: 10.1007/s10875-008-9273-5. Epub 2009 Jan 28.

Abstract

Introduction: Early diagnosis and treatment are keys to improve survival of patients with primary immunodeficiency diseases (PID). The clinical characteristics of these patients in Thailand were not well defined.

Objective: This study aimed to determine the clinical characteristics and outcomes of patients with PID in Thailand.

Methods: Medical records of PID patients in the past 18 years were reviewed.

Results: Sixty-seven children were registered. Antibody deficiencies were the most common PID (52.2%), followed by combined T cell and B cell immunodeficiencies (25.4%), other well-defined immunodeficiency syndromes (11.9%), and phagocytic defects (10.4%). The most common presentations of antibody deficiencies, combined T cell and B cell immunodeficiencies, and phagocytic defects were infection in the upper respiratory tract (74.3%), gastrointestinal tract (82.4%), and skin (85.7%), respectively. The highest mortality rate (52.9%) was found in severe combined immunodeficiency.

Conclusion: These results provide clinical features of PID in Thailand. Knowing these features will lead to prompt diagnosis and appropriate management.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age of Onset
  • Bone Marrow Transplantation
  • Child
  • Child, Preschool
  • DNA Mutational Analysis
  • Early Diagnosis
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / diagnosis*
  • Immunologic Deficiency Syndromes / epidemiology
  • Immunologic Deficiency Syndromes / physiopathology*
  • Immunologic Deficiency Syndromes / therapy
  • Infant
  • Infant, Newborn
  • Male
  • Opportunistic Infections / complications
  • Opportunistic Infections / immunology*
  • Prevalence
  • Respiratory Tract Infections / complications
  • Respiratory Tract Infections / immunology*
  • Thailand
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous